Bath & Body Works (NYSE:BBWI) Upgraded by Barclays to “Equal Weight” Rating

Bath & Body Works (NYSE:BBWIGet Free Report) was upgraded by analysts at Barclays from an “underweight” rating to an “equal weight” rating in a research note issued to investors on Monday,Briefing.com Automated Import reports. The firm currently has a $43.00 price target on the stock, up from their previous price target of $34.00. Barclays‘s price objective would indicate a potential upside of 11.67% from the stock’s current price.

Several other equities research analysts have also commented on BBWI. Piper Sandler upped their price objective on Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research note on Monday, January 6th. Morgan Stanley lowered their price target on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a report on Thursday, November 21st. JPMorgan Chase & Co. upgraded shares of Bath & Body Works from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $41.00 to $47.00 in a research report on Tuesday, February 18th. Telsey Advisory Group restated an “outperform” rating and set a $43.00 target price on shares of Bath & Body Works in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Six analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $44.19.

Get Our Latest Stock Analysis on BBWI

Bath & Body Works Trading Down 4.5 %

Shares of BBWI opened at $38.51 on Monday. The firm has a fifty day simple moving average of $37.70 and a two-hundred day simple moving average of $33.90. The firm has a market cap of $8.34 billion, a PE ratio of 9.39, a P/E/G ratio of 0.96 and a beta of 1.83. Bath & Body Works has a 1-year low of $26.20 and a 1-year high of $52.99.

Bath & Body Works (NYSE:BBWIGet Free Report) last announced its earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.58 billion. During the same period last year, the firm posted $0.48 earnings per share. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. As a group, research analysts forecast that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Golden State Wealth Management LLC purchased a new stake in shares of Bath & Body Works in the 4th quarter worth $26,000. SRS Capital Advisors Inc. raised its holdings in shares of Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock valued at $26,000 after acquiring an additional 329 shares in the last quarter. True Wealth Design LLC grew its holdings in Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after acquiring an additional 1,054 shares in the last quarter. UMB Bank n.a. raised its holdings in shares of Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after purchasing an additional 335 shares in the last quarter. Finally, Lindbrook Capital LLC increased its holdings in Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after buying an additional 431 shares during the period. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Featured Stories

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.